These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8630283)

  • 61. Clinical Application of Pro-Gastrin-Releasing Peptide.
    Fang L; Huang Z; Lin Y; Fu J; Liang X; Liu F
    Clin Lab; 2018 Jul; 64(7):1259-1268. PubMed ID: 30146822
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Determining the cut-off value of pro-gastrin releasing peptide (ProGRP) in lung cancer according to population characteristics.
    Bubanović G; Pavićević R; Franjević A
    Coll Antropol; 2008 Dec; 32(4):1155-64. PubMed ID: 19149223
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
    Akoun GM; Scarna HM; Milleron BJ; Bénichou MP; Herman DP
    Chest; 1985 Jan; 87(1):39-43. PubMed ID: 2981171
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
    Giovanella L; Ceriani L; Bandera M; Garancini S
    Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
    Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy.
    Suzuki H; Takayanagi S; Otake T; Ishibashi R; Osawa S; Shirai T; Takashima M; Hanai H; Kaneko E
    J Gastroenterol; 1999 Jun; 34(3):378-82. PubMed ID: 10433016
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer.
    Kim HR; Oh IJ; Shin MG; Park JS; Choi HJ; Ban HJ; Kim KS; Kim YC; Shin JH; Ryang DW; Suh SP
    J Korean Med Sci; 2011 May; 26(5):625-30. PubMed ID: 21532852
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion].
    Liu Y; Yu L; Lin J
    Zhongguo Fei Ai Za Zhi; 2006 Jun; 9(3):273-6. PubMed ID: 21172161
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission.
    Muley T; Herth FJ; Heussel CP; Kriegsmann M; Thomas M; Meister M; Schneider MA; Wehnl B; Mang A; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S219-S232. PubMed ID: 37840518
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients.
    Yashi M; Muraishi O; Kobayashi Y; Tokue A; Nanjo H
    Prostate; 2002 May; 51(2):84-97. PubMed ID: 11948963
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [On detection of chromogranin A, synaptophysin, neuronspecific enolase and progastrin-releasing peptide in small cell lung cancer].
    Lu QQ; Li J; Li YH; Liu H; Xie XB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jul; 56(7):1017-1022. PubMed ID: 35899358
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cut-off levels of NSE to differentiate SCLC from NSCLC.
    Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K
    Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
    Muley T; Ebert W; Stieber P; Raith H; Holdenrieder S; Nagel D; Fürst H; Roth HJ; Luthe H; Blijenberg BG; Gurr E; Uhl W; von Pawel J; Drings P
    Clin Chem Lab Med; 2003 Jan; 41(1):95-103. PubMed ID: 12636057
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer].
    Zhou J; Xiong Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):90-3. PubMed ID: 7657349
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The usefulness of serum neuron-specific enolase in the clinical management of small-cell lung carcinoma].
    Sánchez de Cos Escuín J; Masa Jiménez F; Disdier Vicente C; de la Cruz Ríos JL; Vergara Fiordia C; Domínguez Retortillo C; Fuentes Otero F
    Arch Bronconeumol; 1994 Oct; 30(8):375-80. PubMed ID: 7987543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
    Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
    Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
    Ni J; Guo Z; Zhang L
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
    Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer.
    Holdenrieder S; von Pawel J; Dankelmann E; Duell T; Faderl B; Markus A; Siakavara M; Wagner H; Feldmann K; Hoffmann H; Raith H; Nagel D; Stieber P
    Clin Cancer Res; 2008 Dec; 14(23):7813-21. PubMed ID: 19047109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.